Recent News for NVIV - InVivo Therapeutics Holdings Corp.

Date Title
Sep 24 The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger
Jul 25 The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug
Jul 16 InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord
Jul 12 InVivo postpones shareholder meeting
Jul 12 InVivo Therapeutics Announces Postponement of Annual Meeting
Jul 10 The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV
Jun 14 InVivo Therapeutics Announces Adjournment of Annual Meeting
Jun 7 The Daily Biotech Pulse: Vertex Bets Big On Gene-Editing Therapies, Sanofi Poaches Novartis For CEO Role, Relief In Europe for Endologix
May 30 The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug
May 29 Bob Langer-founded device-maker InVivo starts new trial after patient deaths
May 29 Enrollment underway in SCI study of InVivo's Neuro-Spinal Scaffold
May 29 InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury
Apr 22 Zynerba Pharmaceuticals and Akorn among healthcare gainers; InVivo Therapeutics and Sesen Bio among losers
Apr 17 InVivo up 2% premarket on new Neuro-Spinal Scaffold data
Apr 17 InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold™ in Acute Thoracic Complete Spinal Cord Injury
Back to the Main NVIV Page...